MEHLEN, PATRICK P,PARADISI, ANDREA A,NONY, PASCALE P,‧梅朗,‧帕拉迪西,‧諾尼
申请号:
HK15109200.0
公开号:
HK1208379A
申请日:
2015.09.18
申请国别(地区):
HK
年份:
2016
代理人:
摘要:
Pharmaceutical composition comprising a chemotherapeutic drug and a netrin-1 interfering drug or a vector capable of expressing a netrin-1 interfering drug in vivo, in a pharmaceutically acceptable carrier or vehicle. The chemotherapeutic drug is selected from those able to induce over expression of netrin-1 in cancer cells. The combination is associated with synergic anti-cancer effect.